These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19920379)

  • 21. Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves.
    Demizu Y; Murakami M; Miyawaki D; Niwa Y; Akagi T; Sasaki R; Terashima K; Suga D; Kamae I; Hishikawa Y
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1487-92. PubMed ID: 19345516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical physics aspects of particle therapy.
    Jäkel O
    Radiat Prot Dosimetry; 2009 Nov; 137(1-2):156-66. PubMed ID: 19828718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proton beam therapy at Shizuoka Cancer Center].
    Murayama S; Fuji H
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1806-12. PubMed ID: 19920382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton therapy in Japan.
    Tsunemoto H; Morita S; Ishikawa T; Furukawa S; Kawachi K; Kanai T; Ohara H; Kitagawa T; Inada T
    Radiat Res Suppl; 1985; 8():S235-43. PubMed ID: 3003785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heavy charged particle radiotherapy--proton beam].
    Ogino T
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2030-5. PubMed ID: 14712761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Particle selection and beam collimation system for laser-accelerated proton beam therapy.
    Luo W; Fourkal E; Li J; Ma CM
    Med Phys; 2005 Mar; 32(3):794-806. PubMed ID: 15839352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbon-ion radiotherapy: clinical aspects and related dosimetry.
    Fukumura A; Tsujii H; Kamada T; Baba M; Tsuji H; Kato H; Kato S; Yamada S; Yasuda S; Yanagi T; Kato H; Hara R; Yamamoto N; Mizoe J; Akahane K; Fukuda S; Furusawa Y; Iwata Y; Kanai T; Kanematsu N; Kitagawa A; Matsufuji N; Minohara S; Miyahara N; Mizuno H; Murakami T; Nishizawa K; Noda K; Takada E; Yonai S
    Radiat Prot Dosimetry; 2009 Nov; 137(1-2):149-55. PubMed ID: 19812127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The National Center for Oncological Hadron Therapy: status of the project and future clinical use of the facility.
    Orecchia R; Fossati P; Rossi S
    Tumori; 2009; 95(2):169-76. PubMed ID: 19579862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton beam therapy in Japan: current and future status.
    Sakurai H; Ishikawa H; Okumura T
    Jpn J Clin Oncol; 2016 Oct; 46(10):885-892. PubMed ID: 27534798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation protection at Hadron therapy facilities.
    Pelliccioni M
    Radiat Prot Dosimetry; 2011 Jul; 146(4):407-13. PubMed ID: 21733860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A beam of hope for heavy ion radiotherapy: Promising clinical results and better designs are adding new momentum to the push for more proton and carbon ion radiotherapy centers.
    Nelson B
    Cancer Cytopathol; 2015 Aug; 123(8):445-6. PubMed ID: 26385868
    [No Abstract]   [Full Text] [Related]  

  • 34. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience.
    Kamada T; Tsujii H; Blakely EA; Debus J; De Neve W; Durante M; Jäkel O; Mayer R; Orecchia R; Pötter R; Vatnitsky S; Chu WT
    Lancet Oncol; 2015 Feb; 16(2):e93-e100. PubMed ID: 25638685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is proton beam therapy the future of radiotherapy? Part I: clinical aspects].
    Bouyon-Monteau A; Habrand JL; Datchary J; Alapetite C; Bolle S; Dendale R; Feuvret L; Helfre S; Calugaru V; Cosset JM; Bey P
    Cancer Radiother; 2010 Dec; 14(8):727-38. PubMed ID: 20427218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ion beam treatment: a new medical treatment system].
    Hishikawa Y; Murakami M
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):377-81. PubMed ID: 18347385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current status and prospectives of proton and heavier-ion beam therapy for tumor in the digestive system].
    Yu JM; Zhu WQ; Meng X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Nov; 14(11):827-9. PubMed ID: 22116714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ion beam radiobiology and cancer: time to update ourselves.
    Fokas E; Kraft G; An H; Engenhart-Cabillic R
    Biochim Biophys Acta; 2009 Dec; 1796(2):216-29. PubMed ID: 19682551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Particle selection for laser-accelerated proton therapy feasibility study.
    Fourkal E; Li JS; Ding M; Tajima T; Ma CM
    Med Phys; 2003 Jul; 30(7):1660-70. PubMed ID: 12906183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.